CC

Commodore Capital Portfolio holdings

AUM $1.42B
1-Year Est. Return 73.3%
This Quarter Est. Return
1 Year Est. Return
+73.3%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$664M
AUM Growth
+$41.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
41
New
Increased
Reduced
Closed

Top Buys

1
+$27.2M
2
+$20.4M
3
+$18.3M
4
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$14M
5
FDMT icon
4D Molecular Therapeutics
FDMT
+$13.3M

Top Sells

1
+$43.3M
2
+$22.3M
3
+$20.7M
4
VRDN icon
Viridian Therapeutics
VRDN
+$19.8M
5
AKRO icon
Akero Therapeutics
AKRO
+$11.3M

Sector Composition

1 Healthcare 100%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$9.35M 1.41%
+1,010,359
27
$8.32M 1.25%
+173,481
28
$6.58M 0.99%
129,041
29
$4.27M 0.64%
993,294
-25,275
30
$3.1M 0.47%
750,000
31
$2.69M 0.41%
498,315
-601,685
32
$2.52M 0.38%
1,800,000
+906,987
33
$2.5M 0.38%
1,210,000
34
$2.11M 0.32%
312,553
35
$142K 0.02%
+9,269
36
– –
-893,646
37
– –
-467,468
38
– –
-205,870
39
– –
-3,711,286
40
– –
-1,975,403
41
– –
-250,000
1
2